Share This Author
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
- L. Swinnen, M. Costanzo-Nordin, R. Fisher
- MedicineThe New England journal of medicine
- 20 December 1990
The addition of OKT3 to the immunosuppressive regimen increases the incidence of post-transplantation lymphoproliferative disorder after cardiac transplantation, and the risk increases sharply after cumulative doses greater than 75 mg.
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass…
It is demonstrated that high- and low-dose aprotinin significantly reduces the requirement for donor-blood transfusion in repeat CABG patients without increasing the risk for perioperative MI.
Predictors of quality of life in patients with advanced heart failure awaiting transplantation.
- K. Grady, A. Jalowiec, M. Costanzo
- Medicine, PsychologyThe Journal of heart and lung transplantation…
Eleven of 19 variables were significant predictors of higher quality of life in patients with advanced heart failure awaiting heart transplantation and accounted for 49% of explained variance.
Early repair of ventricular septal rupture after infarction.
Ventricular aneurysm due to blunt chest injury.
Management of bleeding in cardiovascular surgery
- R. Pifarré
- Medicine, Engineering
Management of Heparin-Induced Thrombocytopenia and Postoperative Bleeding in Cardiovascular Surgery and Pharmacologic Management of Surgical Bleeding: Impact of Newer Antithrombotic and Anticoagulant Drugs.
Diagnostic role of computed tomography in pericardial heart disease: congenital defects, thickening, neoplasms, and effusions.
Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina.